Esperion Therapeutics (ESPR) Interest Coverage Ratio (2012 - 2026)

Esperion Therapeutics has reported Interest Coverage Ratio for 14 years, with the latest figure at 0.33 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio rose 70.77% year-over-year to 0.33; the trailing twelve-month figure through Mar 2026 stood at 0.89 (up 262.69% YoY), and the FY2025 full-year result was 0.71, down 22.41% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.33, down from 3.77 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 5.15 in Q1 2024, with the low at 3.67 in Q2 2022.
• Historically, Interest Coverage Ratio has averaged 1.0 across 5 years, with a median of 1.14 in 2025.
• The largest YoY upside for Interest Coverage Ratio was 2200.52% in 2025 against a maximum downside of 122.07% in 2025.
• Esperion Therapeutics' Interest Coverage Ratio stood at 2.97 in 2022, then advanced by 5.16% to 2.81 in 2023, then soared by 93.63% to 0.18 in 2024, then jumped by 2200.52% to 3.77 in 2025, then sank by 108.83% to 0.33 in 2026.
• The last three Interest Coverage Ratio figures came in at 0.33 (Q1 2026), 3.77 (Q4 2025), and 0.45 (Q3 2025), per Business Quant data.